The Initial Clinical and Electrophysiological Characteristics of Different Subtypes of Guillain–Barré Syndrome Diagnosed Based on Serial Electrophysiological Examinations
Shuo Yang,Na Chen,Lei Zhang,Ying Wang,Lin Chen,Fan Jian,Zaiqiang Zhang,Yilong Wang,Hua Pan
DOI: https://doi.org/10.1002/brb3.70068
IF: 3.1
2024-10-01
Brain and Behavior
Abstract:Our study aimed to identify reversible conduction failure (RCF) early in patients with Guillain–Barré syndrome based on initial clinical and electrophysiological examinations. The early identification of RCF from acute inflammatory demyelinating polyradiculoneuropathy (AIDP) exhibits relatively distinct features, including protein levels in cerebrospinal fluid, distal motor latency, and F‐wave latencies. However, differentiating RCF from axonal degeneration remains challenging, with the Hughes functional grade potentially serving as a distinguishing factor. Background We aimed to identify different Guillain–Barré syndrome (GBS) subtypes, demyelination, axonal degeneration, and reversible conduction failure (RCF) as early as possible by analyzing the initial clinical and electrophysiological examinations. Methods This study retrospectively collected GBS patients between October 2018 and December 2022 at Beijing Tiantan Hospital. The diagnostic criteria for the initial electrophysiological study were based on Rajabally's criteria, and the criteria for the serial electrophysiological study were based on Uncini's criteria. All subjects underwent clinical and electrophysiological evaluations at least twice within 8 weeks. Results A total of 47 eligible patients with GBS were included, comprising 19 acute inflammatory demyelinating polyradiculoneuropathy (AIDP), 18 axonal degenerations, and 10 RCFs. In the RCF group, 40%, 30%, and 30% patients were diagnosed as AIDP, axonal, and equivocal at the initial study, respectively. The AIDP group had significantly higher cerebrospinal fluid (CSF) protein than the RCF (123.8 [106.4, 215.1] mg/dL vs. 67.1 [36.8, 85.6] mg/dL, p = 0.002) and axonal degeneration (123.8 [106.4, 215.1] mg/dL vs. 60.8 [34.8, 113.0] mg/dL, p
behavioral sciences,neurosciences